Too Soon To Say If US FDA Device Reforms Are Working, Says Independent Report

The US Food and Drug Administration has adopted all of the recommendations that consulting firm Booz Allen Hamilton has made in the past two years to improve its medical device review process, but it is still too early to say if the changes have improved overall performance.

More from Archive

More from Medtech Insight